Copeland EM, Dudrick SJNutritional aspects of cancer. IN Current Problems in Cancer , Vol 1. No 3. RC Hickey (ed). Year Book Medical Publishers. Inc. Chicago, IL. 1976
2.
Souchon EA, Copeland EMWatson P., et al: Intravenous hyperalimentation as an adjunct to cancer chemotherapy with 5-fluorouracil. J Surg Res18:451-454, 1975
3.
Moertel CG, Schutt AJHahn RG, et al: Effects of patient selection on results of phase II chemotherapy trials in gastrointestinal cancer. Cancer Chemother Rep58:257-63, 1974
4.
Bertino JR: Nutrients, vitamins, and minerals as therapy. Cancer43:2137-2142, 1979
5.
Issell BF, Valdivieso M., Zaren HA, et al: Protection against chemotherapy toxicity by IV hyperalimentation . Cancer Treat Rep62:1139-1143, 1978
6.
Copeland EM, MacFadyen BV Jr, Lanzotti V., et al: Intravenous hyperalimentation as an adjunct to cancer chemotherapy . Am J Surg129:167-173, 1975
7.
Lanzotti VC, Copeland EM, George SL, et al: Cancer chemotherapeutic response and intravenous hyperalimentation . Cancer Chemother Rep59:437-439, 1975
8.
Valdivieso M. , Bodey G., Benjamin R., et al: Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small bronchogenic carcinoma. Cancer Treat Rep in press
9.
Popp MB, Fisher RI, Simon RM, et al: A prospective, randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma. I. Effect on drug tolerance. Cancer Treat Rep In press
10.
Nixon DW, Moffitt S., Lawson DH, et al: Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep In press
11.
Jordan WM, Valdivieso M., Frankmann C., et al: Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive IV hyperalimentation . Cancer Treat Rep. 65:197-205, 1981
12.
Samuels ML, Selig DE, Ogden S., et al: IV hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep68:615-627, 1981
13.
Popp MB, Fisher RI, Wesley R., et al: A prospective, randomized study of adjuvant parenteral nutrition in the treatment of advanced diffuse lymphoma: influence on survival. Surgery90:195-202, 1981
14.
Brennan MF, Burt ME: Nitrogen metabolism in cancer patients. Cancer Treat Rep In press
15.
van Eys J., Copeland EM, Taylor G., et al: Supportive therapy with curative intent. IN Status of the Curability of Childhood Cancers. J van Eys and M Sullivan (eds). Raven Press, New York, pp 33-46, 1980
16.
van Eys J., Copeland EM, Canigar A. et al. A clinical trial of hyperalimentation in children with metastatic malignancies. Med Pediatr Oncol8:63-73, 1980
17.
Rickard KA, Grosfeld JL, Kirksey A., et al: Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease. Ann Surg190:771-781, 1979
18.
Daly JM, Copeland EM, Dudrick SJ: Effects of intravenous nutrition on tumor growth and host immunocompetence in malnourished animals. Surgery84:655-658, 1978
19.
Daly JM, Reynolds HM, Rowlands BJ, et al: Tumor growth in experimental animals: Nutritional manipulation and chemotherapeutic response. Ann Surg191:316-322, 1980
20.
Steiger E., Oram-Smith J.Miller E. et al Effects of nutrition on tumor growth and tolerance to chemotherapyJ Surg Res18:455-461, 1975
21.
Reynolds HM , Daly JMRowlands BJ, et al Effects of nutritional repletion on host and tumor response to chemotherapy. Cancer45:3069-3074, 1980
